Green to Red with Blue Light: Russian Scientists Uncover Fluorescent Protein s Unexpected Trick | GenomeWeb

Researchers from the Russian Academy of Sciences and Russian biotech firm Evrogen have developed a fluorescent protein that can change its emission from green to red following activation with blue light, the first known fluorescent protein to display such properties.

The discovery is notable because it may allow researchers to conduct so-called pulse-chase experiments to track the movement of organelles and proteins over longer periods in living cells due to the minimal toxicity effects of blue light on living organisms.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.